Former VP at Agilent Technologies Inc
- Trends and developments in the life science instruments sector, focusing on Agilent Technologies (NYSE: A)
- LC-MS (liquid chromatography-mass spectrometry) and gas spectrometry competitive landscape and product comparison across major players
- Agilent’s expansion into NGS (next-generation sequencing) instruments and diagnostics following its April 2021 Resolution Bioscience acquisition
- 2022 outlook and growth expectations, including international expansion in markets such as China with LSAG (Life Sciences and Applied Markets Group)
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.